These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34505229)

  • 1. Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma.
    Baroni LV; Freytes C; Fernández Ponce N; Oller A; Pinto N; Gonzalez A; Maldonado FR; Sampor C; Rugilo C; Lubieniecki F; Alderete D
    J Neurooncol; 2021 Oct; 155(1):53-61. PubMed ID: 34505229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
    Gupta T; Maitre M; Sastri GJ; Krishnatry R; Shirsat N; Epari S; Sahay A; Chinnaswamy G; Patil V; Shetty P; Moiyadi A
    J Neurooncol; 2019 Sep; 144(2):283-291. PubMed ID: 31236820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma.
    Tsang DS; Murray L; Ramaswamy V; Zapotocky M; Tabori U; Bartels U; Huang A; Dirks PB; Taylor MD; Hawkins C; Bouffet E; Laperriere N
    Neuro Oncol; 2019 Mar; 21(4):547-557. PubMed ID: 30452715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma.
    Paulino AC; Ludmir EB; Grosshans DR; Su JM; McGovern SL; Okcu MF; McAleer MF; Baxter PA; Mahajan A; Chintagumpala MM
    Cancer; 2021 Oct; 127(20):3865-3871. PubMed ID: 34254296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study.
    Erker C; Mynarek M; Bailey S; Mazewski CM; Baroni L; Massimino M; Hukin J; Aguilera D; Cappellano AM; Ramaswamy V; Lassaletta A; Perreault S; Kline CN; Rajagopal R; Michaiel G; Zapotocky M; Santa-Maria Lopez V; La Madrid AM; Cacciotti C; Sandler ES; Hoffman LM; Klawinski D; Khan S; Salloum R; Hoppmann AL; Larouche V; Dorris K; Toledano H; Gilheeney SW; Abdelbaki MS; Wilson B; Tsang DS; Knipstein J; Oren MY; Shah S; Murray JC; Ginn KF; Wang ZJ; Fleischhack G; Obrecht D; Tonn S; Harrod VL; Matheson K; Crooks B; Strother DR; Cohen KJ; Hansford JR; Mueller S; Margol A; Gajjar A; Dhall G; Finlay JL; Northcott PA; Rutkowski S; Clifford SC; Robinson G; Bouffet E; Lafay-Cousin L
    J Clin Oncol; 2023 Apr; 41(10):1921-1932. PubMed ID: 36548930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
    Gupta T; Maitre M; Gupta P; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Singh V; Chinnaswamy G; Epari S; Sahay A; Patil V; GodaSastri J
    J Neurooncol; 2020 Apr; 147(2):405-415. PubMed ID: 32072441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.
    Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ
    J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studies.
    Müller K; Mynarek M; Zwiener I; Siegler N; Zimmermann M; Christiansen H; Budach W; Henke G; Warmuth-Metz M; Pietsch T; von Hoff K; von Bueren A; Bode U; Rutkowski S; Kortmann RD; Fleischhack G; Tippelt S
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1019-24. PubMed ID: 24661654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma.
    Napieralska A; Brąclik I; Radwan M; Mandera M; Blamek S
    Childs Nerv Syst; 2019 Feb; 35(2):267-275. PubMed ID: 30515559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
    Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.
    Tringale KR; Wolden SL; Karajannis M; Haque S; Pasquini L; Yildirim O; Rosenblum M; Benhamida JK; Cheung NK; Souweidane M; Basu EM; Pandit-Taskar N; Zanzonico PB; Humm JL; Kramer K
    J Neurooncol; 2023 Mar; 162(1):69-78. PubMed ID: 36853490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients.
    Raleigh DR; Tomlin B; Buono BD; Roddy E; Sear K; Byer L; Felton E; Banerjee A; Torkildson J; Samuel D; Horn B; Braunstein SE; Haas-Kogan DA; Mueller S
    J Neurooncol; 2017 Jan; 131(2):359-368. PubMed ID: 27778212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy?
    Burcu A; Nazan Ç; Özgür Ö; Serra K; Mehmet K; Serap A; Bengü D; Canan V; Haldun Ö; Savaş K; Tuncer T; Taner A; Yeşim E; Ömer K; Yavuz A
    Childs Nerv Syst; 2018 Sep; 34(9):1657-1662. PubMed ID: 29868932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients.
    Massimino M; Sunyach MP; Barretta F; Gandola L; Garegnani A; Pecori E; Spreafico F; Bonneville-Levard A; Meyronet D; Mottolese C; Boschetti L; Biassoni V; Schiavello E; Giussani C; Carrabba G; Diletto B; Pallotti F; Stefini R; Ferrari A; Terenziani M; Casanova M; Luksch R; Meazza C; Podda M; Chiaravalli S; Puma N; Bergamaschi L; Morosi C; Calareso G; Giangaspero F; Antonelli M; Buttarelli FR; Frappaz D
    J Neurooncol; 2020 Jul; 148(3):619-628. PubMed ID: 32567042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omission of Upfront Craniospinal Irradiation in Patients with Low-Risk WNT-Pathway Medulloblastoma Is Associated with Unacceptably High Risk of Neuraxial Failure.
    Gupta T; Pervez S; Dasgupta A; Chatterjee A; Epari S; Chinnaswamy G; Jalali R
    Clin Cancer Res; 2022 Oct; 28(19):4180-4185. PubMed ID: 35653134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scoliosis in Children Treated With Photon Craniospinal Irradiation for Medulloblastoma.
    Paulino AC; Suzawa HS; Dreyer ZE; Hanania AN; Chintagumpala M; Okcu MF
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):712-717. PubMed ID: 33516438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy.
    Paulino AC
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):543-7. PubMed ID: 12062595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose craniospinal radiation therapy for medulloblastoma.
    Halberg FE; Wara WM; Fippin LF; Edwards MS; Levin VA; Davis RL; Prados MB; Wilson CB
    Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):651-4. PubMed ID: 2004939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The change in patterns of relapse in medulloblastoma.
    Tarbell NJ; Loeffler JS; Silver B; Lynch E; Lavally BL; Kupsky WJ; Scott RM; Sallan SE
    Cancer; 1991 Oct; 68(7):1600-4. PubMed ID: 1893359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma).
    Goldwein JW; Radcliffe J; Johnson J; Moshang T; Packer RJ; Sutton LN; Rorke LB; D'Angio GJ
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):899-904. PubMed ID: 8598368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.